azacitidine has been researched along with Cardiomyopathy, Dilated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, G; Li, Y; Mu, Y; Zeng, Q | 1 |
| Jin, L; Piao, J; Yang, S; Zhou, Y | 1 |
2 other study(ies) available for azacitidine and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Transplantation of induced bone marrow mesenchymal stem cells improves the cardiac function of rabbits with dilated cardiomyopathy via upregulation of vascular endothelial growth factor and its receptors.
Topics: Animals; Azacitidine; Blood Pressure; Bone Marrow Cells; Bone Marrow Transplantation; Cardiomyopathy, Dilated; Disease Models, Animal; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rabbits; Receptors, Vascular Endothelial Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation; Vascular Endothelial Growth Factor A | 2011 |
Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?
Topics: Animals; Azacitidine; Body Weight; Bone Marrow Cells; Bromodeoxyuridine; Cardiomyopathy, Dilated; Cell Transdifferentiation; Collagen; Female; Fibrosis; Gene Expression Regulation; Heart Function Tests; Infusions, Intravenous; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Wistar; RNA, Messenger; Survival Analysis; Troponin T; Vascular Endothelial Growth Factor A | 2013 |